Sanofi’s dengue vaccine candidate completes efficacy study
Second large-scale phase III study successfully meets primary endpoint with overall vaccine efficacy of 60.8 per cent and shows…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.